Faster paths to proof of concept

Published on: Feb 19, 2026

Follow us on:

Accelerating clinical development is critical for small and mid-sized biotech companies, where reaching proof of concept efficiently allows them to make the best use of resources and focus on products most likely to succeed. We surveyed 120 biotech decision makers and conducted in-depth interviews with 10 executives to identify the strategies and challenges most impacting their success. Success requires taking advantage of every available strategy, from advances in technology to emerging regions for research, as biotechs that combine multiple acceleration approaches will reach proof of concept faster and more efficiently. 
 
What are the key strategies biotech leaders are prioritizing? How can you leverage innovative trial designs, global expansion, and regulatory pathways to accelerate your development timelines? Which emerging technologies will have the greatest impact on your programs? Download the report to learn how we can help you accelerate your path to proof of concept.


Get Exclusive PDF Access

Explore more episodes